CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Altana

For profitContributed to NME

Also known as: ALTANA | Altana Pharma AG, D-78467 Konstanz, Germany, info.clintrials@altanapharma.com | Altana Pharma, D-78467 Konstanz, Germany

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2005

First marketed drug

Jan 1, 1977

First NDA

Oct 1, 2004

Last known activity

Nov 1, 2005

Acquired by Nycomed (1999) → Takeda on Jan 1, 2006

Timeline

1970s

  1. Jan 1, 1977

    Altana— Founded

  2. Jan 1, 1977

    Byk— Acquired

1990s

  1. Aug 23, 1991

    erythromycin— Marketing Organization

2000s

  1. Oct 1, 2004

    terconazole— NDA Organization

  2. Jan 1, 2006

    Nycomed (1999)— Acquired By

2010s

  1. Oct 3, 2011

    Takeda— Now

Drugs by trial phase (1 distinct, 2 trials)

Phase 4 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (11)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (2)

Details

Founded
Wesel, DE Jan 1, 1977
First NDA
Oct 1, 2004
Last known activity
Nov 1, 2005